These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 26958930)

  • 21. Optimal bacteriophage mutation rates for phage therapy.
    Kysela DT; Turner PE
    J Theor Biol; 2007 Dec; 249(3):411-21. PubMed ID: 17904162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phage therapy--history from Twort and d'Herelle through Soviet experience to current approaches.
    Chanishvili N
    Adv Virus Res; 2012; 83():3-40. PubMed ID: 22748807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. "My enemy's enemy is my friend." Using phages to fight bacteria.
    Bradbury J
    Lancet; 2004 Feb; 363(9409):624-5. PubMed ID: 14989277
    [No Abstract]   [Full Text] [Related]  

  • 24. Bacteriophages as anti-infective agents: recent developments and regulatory challenges.
    Gilmore BF
    Expert Rev Anti Infect Ther; 2012 May; 10(5):533-5. PubMed ID: 22702317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phage therapy in clinical practice: treatment of human infections.
    Kutter E; De Vos D; Gvasalia G; Alavidze Z; Gogokhia L; Kuhl S; Abedon ST
    Curr Pharm Biotechnol; 2010 Jan; 11(1):69-86. PubMed ID: 20214609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The next generation of bacteriophage therapy.
    Lu TK; Koeris MS
    Curr Opin Microbiol; 2011 Oct; 14(5):524-31. PubMed ID: 21868281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phage therapy: a reappraisal of bacteriophages as antibiotics.
    Inal JM
    Arch Immunol Ther Exp (Warsz); 2003; 51(4):237-44. PubMed ID: 12956433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and efficacy of phage therapy via the intravenous route.
    Speck P; Smithyman A
    FEMS Microbiol Lett; 2016 Feb; 363(3):. PubMed ID: 26691737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacteria-phage interactions in natural environments.
    Díaz-Muñoz SL; Koskella B
    Adv Appl Microbiol; 2014; 89():135-83. PubMed ID: 25131402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacteriophage-based pathogen detection.
    Ripp S
    Adv Biochem Eng Biotechnol; 2010; 118():65-83. PubMed ID: 19475368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacteriophage-derived vectors for targeted cancer gene therapy.
    Pranjol MZ; Hajitou A
    Viruses; 2015 Jan; 7(1):268-84. PubMed ID: 25606974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Manufacturing and device options for the delivery of biotherapeutics.
    Hoe S; Boraey MA; Ivey JW; Finlay WH; Vehring R
    J Aerosol Med Pulm Drug Deliv; 2014 Oct; 27(5):315-28. PubMed ID: 24299502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Staphylococcus bacteriophage tails with bactericidal properties: new findings.
    Biddappa AC; Sundarrajan S; Ramalinga AB; Sriram B; Padmanabhan S
    Biotechnol Appl Biochem; 2012; 59(6):495-502. PubMed ID: 23586960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What is needed for phage therapy to become a reality in Western medicine?
    Brüssow H
    Virology; 2012 Dec; 434(2):138-42. PubMed ID: 23059181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacteriophages as an alternative strategy for fighting biofilm development.
    Parasion S; Kwiatek M; Gryko R; Mizak L; Malm A
    Pol J Microbiol; 2014; 63(2):137-45. PubMed ID: 25115107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The potential of phage therapy in bacterial infections of the eye.
    Górski A; Targońska M; Borysowski J; Weber-Dabrowska B
    Ophthalmologica; 2009; 223(3):162-5. PubMed ID: 19155637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacteriophages in the experimental treatment of Pseudomonas aeruginosa infections in mice.
    Saussereau E; Debarbieux L
    Adv Virus Res; 2012; 83():123-41. PubMed ID: 22748810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bacteriophage therapy against staphylococci.
    Klem J; Dömötör D; Schneider G; Kovács T; Tóth A; Rákhely G
    Acta Microbiol Immunol Hung; 2013 Dec; 60(4):411-22. PubMed ID: 24292085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacteriophage therapy: a potential solution for the antibiotic resistance crisis.
    Golkar Z; Bagasra O; Pace DG
    J Infect Dev Ctries; 2014 Feb; 8(2):129-36. PubMed ID: 24518621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacteriophage therapy: exploiting smaller fleas.
    Deresinski S
    Clin Infect Dis; 2009 Apr; 48(8):1096-101. PubMed ID: 19275495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.